EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $296,000 | +17.5% | 5,654 | +8.4% | 0.01% | +20.0% |
| Q2 2019 | $252,000 | -3.1% | 5,214 | +1.3% | 0.01% | 0.0% |
| Q1 2019 | $260,000 | -14.8% | 5,148 | 0.0% | 0.01% | -28.6% |
| Q4 2018 | $305,000 | -9.5% | 5,148 | +0.4% | 0.01% | 0.0% |
| Q3 2018 | $337,000 | +30.6% | 5,126 | +0.4% | 0.01% | +40.0% |
| Q2 2018 | $258,000 | -45.9% | 5,104 | -46.7% | 0.01% | 0.0% |
| Q1 2018 | $477,000 | +129.3% | 9,570 | +114.3% | 0.01% | 0.0% |
| Q4 2017 | $208,000 | +38.7% | 4,466 | +20.8% | 0.01% | +66.7% |
| Q3 2017 | $150,000 | +66.7% | 3,696 | +38.8% | 0.00% | +50.0% |
| Q2 2017 | $90,000 | +136.8% | 2,662 | +101.7% | 0.00% | +100.0% |
| Q1 2017 | $38,000 | -55.3% | 1,320 | -49.2% | 0.00% | -50.0% |
| Q4 2016 | $85,000 | – | 2,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
| Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
| AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
| PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
| SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |